You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Last Updated: May 26, 2020

DrugPatentWatch Database Preview

Hikma Farmaceutica Company Profile

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the competitive landscape for HIKMA FARMACEUTICA, and what generic and branded alternatives to HIKMA FARMACEUTICA drugs are available?

HIKMA FARMACEUTICA has forty approved drugs.

Summary for Hikma Farmaceutica

US Patents:	0
Tradenames:	36
Ingredients:	30
NDAs:	40

Drugs and US Patents for Hikma Farmaceutica

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma Farmaceutica	FLUCONAZOLE IN DEXTROSE 5% IN PLASTIC CONTAINER	fluconazole	INJECTABLE;INJECTION	078764-002	Jan 30, 2012		DISCN	No	No		Start Trial				Start Trial
Hikma Farmaceutica	IRINOTECAN HYDROCHLORIDE	irinotecan hydrochloride	INJECTABLE;INJECTION	091032-001	Dec 20, 2010	AP	RX	No	No		Start Trial				Start Trial
Hikma Farmaceutica	FLUCONAZOLE IN SODIUM CHLORIDE 0.9%	fluconazole	INJECTABLE;INJECTION	076736-001	Aug 23, 2005	AP	RX	No	No		Start Trial				Start Trial
Hikma Farmaceutica	GLYCOPYRROLATE	glycopyrrolate	INJECTABLE;INJECTION	090963-001	Sep 21, 2011	AP	RX	No	Yes		Start Trial				Start Trial
Hikma Farmaceutica	DILTIAZEM HYDROCHLORIDE	diltiazem hydrochloride	INJECTABLE;INJECTION	202651-001	Aug 9, 2012	AP	RX	No	No		Start Trial				Start Trial
Hikma Farmaceutica	CEFTRIAXONE	ceftriaxone sodium	INJECTABLE;INTRAMUSCULAR, INTRAVENOUS	065342-004	Jan 10, 2008	AP	RX	No	No		Start Trial				Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Merck

Dow

Harvard Business School

McKinsey

Baxter

Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

By using our website you are consenting to our use of cookies in accordance with our privacy policy.